Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

NCT02119468 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Refractory Plasma Cell Myeloma
Recurrent Plasma Cell Myeloma

Interventions

DRUG: ixazomib citrate
DRUG: dexamethasone
DRUG: pomalidomide

Sponsor

City of Hope Medical Center

Collaborators

[object Object]